Ticker Details
Merck & Co., Inc. Merck & Co Inc is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products.
IPO Date:	January 2, 1990
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$303.45B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.53 | 0.90%
Avg Daily Range (30 D):	$1.26 | 1.11%
Avg Daily Range (90 D):	$1.12 | 1.11%

Institutional Daily Volume
Avg Daily Volume:	10.59M
Avg Daily Volume (30 D):	10.13M
Avg Daily Volume (90 D):	10.37M

Trade Size
Avg Trade Size (Sh.):	171
Avg Trade Size (Sh.) (30 D):	68
Avg Trade Size (Sh.) (90 D):	71

Institutional Trades
Total Institutional Trades:	173,824
Avg Institutional Trade:	$5.81M
Avg Institutional Trade (30 D):	$13.85M
Avg Institutional Trade (90 D):	$13.23M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	30

Market Closing Trades
Avg Closing Trade:	$84.13M
Avg Closing Trade (30 D):	$203.04M
Avg Closing Trade (90 D):	$213.06M
Avg Closing Volume:	1.14M

News

Feb 23, 2026 @ 9:37 PM 1 Reason I'd Buy Veeva Systems Stock and Never Sel... Source: Prosper Junior Bakiny

Feb 23, 2026 @ 2:16 PM Merck's Strategic Shift Signals New Growth Horizon... Source: Vandana Singh

Feb 19, 2026 @ 12:56 PM Merck Discloses Positive Data For Respiratory Sync... Source: Vandana Singh

Feb 18, 2026 @ 6:05 PM Merck Inks AI Drug Discovery Deal With Mayo Clinic... Source: Vandana Singh

Feb 18, 2026 @ 3:10 PM FDA Grants Breakthrough Status To Johnson & Johnso... Source: Vandana Singh

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$7.58	$2.32	$1.76
Diluted EPS	$7.57	$2.32	$1.76
Revenue	$64.24B	$17.28B	$15.81B
Gross Profit	$49.58B	$13.42B	$12.25B
Net Income / Loss	$19.05B	$5.79B	$4.43B
Operating Income / Loss	$21.82B	$6.75B	$5B
Cost of Revenue	$14.66B	$3.86B	$3.56B
Net Cash Flow	$3.57B	$10.19B	$-659M
PE Ratio	16.37